Pasithea Therapeutics Corp. - Warrant

Share · US70261F1113 · KTTAW (XNAS)

No Price

12.12.2025 20:43

Current Prices from Pasithea Therapeutics Corp. - Warrant

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	KTTAW	USD	12.12.2025 20:43	0,03 USD	-0,007 USD -18,92 %

Share Float & Liquidity

Free Float 98,36 %

Shares Float 7,32 M

Shares Outstanding 7,44 M

Company Profile for Pasithea Therapeutics Corp. - Warrant Share

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.

Get up to date insights from finAgent about Pasithea Therapeutics Corp. - Warrant

Company Data

Name Pasithea Therapeutics Corp. - Warrant

Company Pasithea Therapeutics Corp.

Symbol KTTAW

Website http://pasitheaclinics.com

Primary Exchange

NASDAQ

ISIN US70261F1113

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Tiago Reis Marques

Country United States of America

Currency USD

Employees 0,0 T

Address 1111 Lincoln Road, 33139 Miami Beach

IPO Date 2021-09-15

Ticker Symbols

Name	Symbol
NASDAQ	KTTAW

More Shares

Investors who hold Pasithea Therapeutics Corp. - Warrant also have the following shares in their portfolio:

BMO Low Volatility Equity Fund Class A Fund

EIB 19/22 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog